Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling

被引：3
作者：
Chhatwal, Jagpreet [1 ]
Tapper, Elliot B. [2 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02115 USA
[2] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 02期
基金：
美国国家卫生研究院;
关键词：
COST-EFFECTIVENESS; FIBROSIS STAGE; MORTALITY; IMPACT; NAFLD;
D O I：
10.1016/j.cgh.2022.01.041
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：280 / 282
页数：3
相关论文
共 14 条
  • [1] Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
    Caro, J. Jaime
    Briggs, Andrew H.
    Siebert, Uwe
    Kuntz, Karen M.
    [J]. MEDICAL DECISION MAKING, 2012, 32 (05) : 667 - 677
  • [2] The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2012, 55 (06) : 2005 - 2023
  • [3] Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
    Chhatwal, Jagpreet
    Kanwal, Fasiha
    Roberts, Mark S.
    Dunn, Michael A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 162 (06) : 397 - U114
  • [4] Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
    Ekstedt, Mattias
    Hagstrom, Hannes
    Nasr, Patrik
    Fredrikson, Mats
    Stal, Per
    Kechagias, Stergios
    Hultcrantz, Rolf
    [J]. HEPATOLOGY, 2015, 61 (05) : 1547 - 1554
  • [5] Disease Progression Modeling for Economic Evaluation in Nonalcoholic Fatty Liver Disease-A Systematic Review
    Gruneau, Lina
    Ekstedt, Mattias
    Kechagias, Stergios
    Henriksson, Martin
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) : 283 - 298
  • [6] EVIDENCE-BASED MEDICINE - A NEW APPROACH TO TEACHING THE PRACTICE OF MEDICINE
    GUYATT, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (17): : 2420 - 2425
  • [7] Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Hultcrantz, Rolf
    Kechagias, Stergios
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1265 - 1273
  • [8] The global NAFLD epidemic
    Loomba, Rohit
    Sanyal, Arun J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (11) : 686 - 690
  • [9] Myers E., 2011, EVALUATING POTENTIAL
  • [10] Roberts MS, 2017, METHODS COMP EFFECTI, P429
12